Insights

Gathering insights about Arsanis…

Similar companies to Arsanis

Arsanis Tech Stack

Arsanis uses 8 technology products and services including SiteCatalyst, Drupal, Webpack, and more. Explore Arsanis's tech stack below.

SiteCatalyst
Analytics
Drupal
Content Management System
Webpack
Development
Backbone.js
Javascript Frameworks
Modernizr
Javascript Libraries
UNIX
Operating Systems
Yoast SEO
Search Engines
Popup Maker
Web Platform Extensions

Media & News

X4 Pharmaceuticals attended event Guggenheim Second Annual Healthcare Innovation Conference on Nov 1st '25.
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) - X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare hematology diseases, today announced that the management team will participate in the upcoming Guggenheim Second Annual Healthcare Innovation Conference on November 10-12, 2025 in Boston.
Nov 05, 2025 | www.globenewswire.com
X4 Pharmaceuticals attends event 30th Annual EHA Congress.
X4 Pharmaceuticals announces upcoming presentation of Phase 2 Chronic Neutropenia Trial data at the 30th Annual EHA Congress.
May 14, 2025 | www.globenewswire.com
X4 Pharmaceuticals attends event 30th Annual Congress of the European Hematology Association.
BOSTON, May 14, 2025 (GLOBE NEWSWIRE) - X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced the acceptance of two abstracts for poster presentation at the 30th Annual Congress of the European Hematology Association (EHA) taking place in Milan, Italy from June 12-15, 2025.
May 14, 2025 | www.globenewswire.com
X4 Pharmaceuticals launches Phase 2 Chronic Neutropenia Trial data at 30th Annual EHA Congress.
X4 Pharmaceuticals announces upcoming presentation of Phase 2 Chronic Neutropenia Trial data at the 30th Annual EHA Congress.
May 14, 2025 | www.globenewswire.com
X4 Pharmaceuticals decreased headcount by 43 on Feb 13th '25.
X4 Pharmaceuticals announced Thursday it is laying off 43 people, about 30% of its employees worldwide.
Feb 06, 2025 | www.biospace.com
X4 Pharmaceuticals closes offices in Vienna, Austria.
X4 Pharmaceuticals shuttered its early-stage research efforts and closed down its campus in Vienna, Austria, in a bid to consolidate its resources on the commercialisation and development of its sole marketed product, Xolremdi (mavorixafor).
Feb 06, 2025 | firstwordpharma.com
X4 Pharmaceuticals partnered with Norgine Pty on Jan 27th '25.
Earlier this month X4 announced an exclusive licensing and supply agreement with Norgine to commercialize mavorixafor in Europe, Australia, and New Zealand.
Jan 27, 2025 | pharmabiz.com

Arsanis's Email Address Formats

Arsanis uses at least 2 format(s):

Arsanis Email Formats	Example	Percentage
First.Last@arsanis.com	John.Doe@arsanis.com	93%
FLast@arsanis.com	JDoe@arsanis.com	7%
First.Last@x4pharma.com	John.Doe@x4pharma.com	100%

Frequently Asked Questions

What is Arsanis's phone number?

You can contact Arsanis's main corporate office by phone at

+1-603-727-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Arsanis's stock symbol?

Arsanis is a publicly traded company; the company's stock symbol is XFOR.

What is Arsanis's official website and social media links?

Arsanis's official website is x4pharma.com and has social profiles on LinkedIn Crunchbase.

What is Arsanis's SIC code NAICS code?

Arsanis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arsanis have currently?

As of December 2025, Arsanis has approximately 11 employees across 2 continents, including North AmericaEurope. Key team members include Director Of Finance & Operations: J. S.Clinical Trial Manager: L. M.Senior Executive Assistant/Office Manager: M. C.. Explore Arsanis's employee directory with LeadIQ.

What industry does Arsanis belong to?

Arsanis operates in the Biotechnology Research industry.

What technology does Arsanis use?

Arsanis's tech stack includes SiteCatalystDrupalWebpackBackbone.jsModernizrUNIXYoast SEOPopup Maker.

What is Arsanis's email format?

Arsanis's email format typically follows the pattern of First.Last@arsanis.com. Find more Arsanis email formats with LeadIQ.

How much funding has Arsanis raised to date?

As of December 2025, Arsanis has raised $20M in funding. The last funding round occurred on Dec 04, 2017 for $20M.

When was Arsanis founded?

Arsanis was founded in 2010.

Arsanis

Q: What is Arsanis's official website and social media links?

Arsanis's official website is x4pharma.com. Arsanis has social profiles on LinkedIn.

Q: How many employees does Arsanis have currently?

Arsanis has approximately 11 employees.

Q: What technology does Arsanis use?

Arsanis's tech stack includes Adobe Fonts, SAS/STAT, DocuSign, Backbone.js, jQuery.

Biotechnology ResearchMassachusetts, United States11-50 Employees

Effective March 13, 2019, Arsanis completed a merger with X4 Pharmaceuticals, Inc. For continued news and updates, we encourage you to follow X4 at www.x4pharma.com to stay in touch and learn more.

Company Overview

Phone number: +1-603-727-****
Website: x4pharma.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: XFOR
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2010
Employees: 11-50

Media & News

Funding & Financials

$20M
Arsanis has raised a total of $20M of funding over 9 rounds. Their latest funding round was raised on Dec 04, 2017 in the amount of $20M.
$1M$10M
Arsanis's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$20M
Arsanis has raised a total of $20M of funding over 9 rounds. Their latest funding round was raised on Dec 04, 2017 in the amount of $20M.
$1M$10M
Arsanis's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Arsanis

Quell Therapeutics

Generation Bio

Semma Therapeutics

LogicBio Therapeutics

BlueRock Therapeutics

Guardant Health

AVROBIO

Intergamma

Arsanis Tech Stack

Media & News

X4 Pharmaceuticals attended event Guggenheim Second Annual Healthcare Innovation Conference on Nov 1st '25.

X4 Pharmaceuticals attends event 30th Annual EHA Congress.

X4 Pharmaceuticals attends event 30th Annual Congress of the European Hematology Association.

X4 Pharmaceuticals launches Phase 2 Chronic Neutropenia Trial data at 30th Annual EHA Congress.

X4 Pharmaceuticals decreased headcount by 43 on Feb 13th '25.

X4 Pharmaceuticals closes offices in Vienna, Austria.

X4 Pharmaceuticals partnered with Norgine Pty on Jan 27th '25.

Arsanis's Email Address Formats

Frequently Asked Questions

What is Arsanis's phone number?

What is Arsanis's stock symbol?

What is Arsanis's official website and social media links?

What is Arsanis's SIC code NAICS code?

How many employees does Arsanis have currently?

What industry does Arsanis belong to?

What technology does Arsanis use?

What is Arsanis's email format?

How much funding has Arsanis raised to date?

When was Arsanis founded?

Arsanis

Company Overview

Media & News

X4 Pharmaceuticals attended event Guggenheim Second Annual Healthcare Innovation Conference on Nov 1st '25.

X4 Pharmaceuticals attends event 30th Annual EHA Congress.

X4 Pharmaceuticals attends event 30th Annual Congress of the European Hematology Association.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?